Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
59M
-
Shares change
-
-329K
-
Total reported value, excl. options
-
$6.32B
-
Value change
-
-$30.9M
-
Put/Call ratio
-
1.58
-
Number of buys
-
114
-
Number of sells
-
-137
-
Price
-
$107.11
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2021
313 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2021.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59M shares
of 65M outstanding shares and own 90.7% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.53M shares), BlackRock Inc. (5.34M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.55M shares), WELLINGTON MANAGEMENT GROUP LLP (3.48M shares), FMR LLC (2.35M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.75M shares), STATE STREET CORP (1.73M shares), JPMORGAN CHASE & CO (1.64M shares), Casdin Capital, LLC (1.55M shares), and ALLIANCEBERNSTEIN L.P. (1.5M shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.